An open source solution for an in-house built dynamic platform for the validation of stereotactic ablative body radiotherapy for VMAT and IMRT

Australasian Physical and Engineering Sciences in Medicine

Volumn 39, Issue 4, 2016, Pages 957-964

  Munoz, Luis ^a   Ziebell, Amy ^a   Morton, Jason ^a   Bhat, Madhava ^a  

^a Genesis Cancer Care   (Australia)

Author keywords

Gafchromic EBT3 film; Motion management; Open source; Stereotactic ablative body radiation therapy (SABR)

Indexed keywords

BIOMEDICAL ENGINEERING; OPEN SOURCE SOFTWARE; OPEN SYSTEMS; QUALITY ASSURANCE; RADIOTHERAPY;

ANTHROPOMORPHIC PHANTOMS; HIGH-TORQUE SERVO MOTORS; MICROCONTROLLER BOARDS; MOTION MANAGEMENT; MULTILEAF COLLIMATORS; OPEN SOURCES; OPEN-SOURCE HARDWARES; STEREOTACTIC ABLATIVE BODY RADIATION THERAPY (SABR);

COMPUTERIZED TOMOGRAPHY;

ARTICLE; CANCER RADIOTHERAPY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER; COMPUTER ASSISTED TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY; CONTROL SYSTEM; FILM DOSIMETER; FILM DOSIMETRY; IMAGING PHANTOM; INTENSITY MODULATED RADIATION THERAPY; LUNG MECHANICS; MULTILEAF COLLIMATOR; QUALITY CONTROL; RADIOTHERAPY PLANNING SYSTEM; STEREOTACTIC ABLATIVE BODY RADIOTHERAPY; STEREOTACTIC BODY RADIATION THERAPY; VOLUMETRIC MODULATED ARC THERAPY; CALIBRATION; HUMAN; PROCEDURES; RADIATION RESPONSE; RADIOSURGERY; REPRODUCIBILITY; TUMOR VOLUME;

CALIBRATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FILM DOSIMETRY; HUMANS; PHANTOMS, IMAGING; RADIOSURGERY; RADIOTHERAPY, INTENSITY-MODULATED; REPRODUCIBILITY OF RESULTS; TUMOR BURDEN;

EID: 84988431524     PISSN: 01589938     EISSN: 18795447     Source Type: Journal    
DOI: 10.1007/s13246-016-0484-4     Document Type: Article

References (34)

1. Wooten L, Therriault-Proulx F, Beddar S (2015) What can the medical physics field learn from the open source hardware community? Med Phys 42:3231
2. Haasbeek CJ, Slotman BJ, Senan S (2009) Radiotherapy for lung cancer: clinical impact of recent technical advances. Lung Cancer 64(1):1–8
3. Blomgren H, Lax I, Näslund I, Svanström R (1995) Stereotactic high dose fraction radiation therapy of extracranial tumours using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34:861–870
4. Goldsmith C, Gaya A (2012) Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours. Cancer Imaging 12(2):351–360
5. Herbert C, Kwa W, Nakano S, James K, Moiseenko V, Schellenberg D, Liu M (2013) Stereotactic body radiotherapy: volumetric modulated arc therapy versus 3D non-coplanar conformal radiotherapy for the treatment of early stage lung cancer. Technol Cancer Res Treat 12(6):511–516
6. Spiotto M, Loo B, Chang D (2009) Stereotactic body radiotherapy for primary and oligometastatic cancers. Community Oncol 6:456–462
7. Leer JWH, McKenzie AL, Scalliet P, Thwaites D I (1998) Practical guidelines for the implementation of a quality system in radiotherapy. ESTRO Mounierlaan 83/4-1200 Brussel
8. Van Dyk J (2009) Commissioning and implementation of a quality assurance programme for new technologies. In: Book of extended synopsis of international conference on advances in radiation oncology (ICARO) Vienna
9. Schreiner J (2011) On the quality assurance and verification of modern radiation therapy treatment. J Med Phys 36(4):189–191
10. Viel F, Gete E, Duzenli C, Lee R (2013) Developing QA procedures for gated VMAT SABR treatments. Med Phys 40:100
11. Hrbacek J, Lang S, Graydon SN, Klock S, Riesterer O (2014) Dosimetric comparison of flattened and unflattened beams for stereotactic ablative radiotherapy of stage I non-small cell lung cancer. Med Phys 41(3):031709:1–031709:7
12. McGarry CK, OConnell BF, Grattan MWD, Agnew CE, Irvine DM, Hounsell AR (2013) Octavius 4D characterization for flattened and flattening filter free rotational deliveries. Med Phys 40(9):091707
13. Admiraal MA, Schuring D, Hurkmans CW (2008) Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume. Radiother Oncol 86:55–60
14. Reinhardt A, Hillbrand M, Wilkens JJ, Assmann W (2012) Comparison of Gafchromic EBT2 and EBT3 films for clinical photon and proton beams. Med Phys 39(8):5257–5262
15. Hardcastle N, Basavatia A, Bayliss A, Tome WA (2011) High dose per fraction dosimetry of small fields with Gafchromic EBT2 film. Med Phys 38(7):4081–4085
16. Cusumano D, Fumagalli M, Marchetti M, Fariselli L, De Martin E (2015) Dosimetric verification of stereotactic radiosurgery/stereotactic radiotherapy dose distributions using Gafchromic EBT3. Med Dosim 40:226–331
17. Viel F, Gete E, Duzenli C, Lee R (2013) Developing QA procedures for gated VMAT SABR treatments. Med Phys 40:100
18. Chaudhari S, Goddu S, Mutic S, Esthappan J, Kawamura S, Low D (2006) Dosimetric validation of tomotherapy in heterogeneous media. Med Phys 33:2093
19. Chi A, Nguyen NP, Komaki R (2014) The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases. Front Oncol 4(151):1–12
20. Britton K, Starschall G, Tucker S, Pan T, Nelson C, Chang J (2007) Assessment of gross tumour volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 68(4):1036–1046
21. Stankovic U, Ploeger LS, Sonke JJ, Van-Herk M (2016) Clinical introduction of image lag correction for a cone beam CT system. Med Phys 43(3):1057–1064
22. Parsons D, Robar J (2015) An investigation of kV CBCT image quality and dose reduction for volume-of-interest imaging using dynamic collimation. Med Phys 42:5258
23. Patel R, Sengottuvel S, Gireesan K, Janawadkar MP, Radhakrishnan TS (2015) Extraction of breathing pattern using temperature sensor based on Arduino board. AIP Conf Proc 1665:060007
24. Lee S, Choi S, Min C, Ji Y, Jung H, Kim M, Yoo H, Kim C, Yi C, Kim K (2014) Study of variation of internal target volume between 4DCT and slow-ct in respiratory patterns using respiratory motion phantom. Med Phys 41:180
25. Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, Schild SE, Komaki R, Urbanic JJ, Choy H (2015) A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG oncology RTOG 0915 (NCCTG N0927). Int J Radiation Oncol Biol Phys 93(4):757–764
26. Beaudry J, Cropp R, Bergman A (2015) Reconstructing 4D cone beam CT images for clinical QA of lung SABR treatments. Med Phys 42:3300
27. Fiandra C, Ricardi U, Ragona R (2006) Clinical use of EBT model Gafchromic film in radiotherapy. Med Phys 33:4314–4319
28. Saur S, Frengen J (2008) GafChromic EBT film dosimetry with flatbed CCD scanner: a novel background correction method and full dose uncertainty analysis. Med Phys 35(7):3094–3101
29. Fiandra C, Fusella M, Giglioli FR, Filippi AR, Mantovani C, Ricardi U, Ragona R (2013) Comparison of Gafchromic EBT2 and EBT3 for patient-specific quality assurance: cranial stereotactic radiosurgery using volumetric modulated arc therapy with multiple non-coplanar arcs. Med Phys 40(8):082105:1–082105:8
30. Perez-Azorin J, Ramos-Garcia L, Marti-Clement J (2014) A method for multichannel dosimetry with EBT3 radiochromic films. Med Phys 41(6):062101-1–062101-10
31. Casanova-Borca V, Pasquino M, Russo G, Grosso P, Cante D, Sciacero P, Girelli G, Rosa la Porta M, Tofani S (2013) GAFCHROMIC EBT3 film for IMRT dose verification. J Appl Clin Med Phys 14:158–171
32. Low D, Dempsey J (2003) Evaluation of the gamma dose distribution comparison method. Med Phys 30(9):2455–2464
33. Nakamura M, Narita Y, Matsuo Y, Narabayashi M, Nakata M, Yano S (2008) Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumours in the upper and middle lobe. Med Phys 35(8):4142–4148
34. Stambaugh C, Nekns BE, Dilling T, Stevens C, Latifi K, Zhang G, Moros E, Feygelman V (2013) Experimentally studied dynamic dose interplay does not meaningfully affect target dose in VMAT SBRT lung treatments. Med Phys 40:091710